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systemic side effects compared to inactivated JE vaccine.
Since antibody (Ab) titers to vaccine-preventable diseases
decline after hematopoietic stem cell transplantation (HSCT),
therefore reimmunization recommendations have been
developed for post HSCT survivors. However, there has been
no recommendation for revaccination of JE vaccine in post
HSCT recipients. This study aimed to measure the immuno-
genic response to the live-attenuated JE vaccine (SA 14-14-2)
in post HSCT recipients. We enrolled patients who under-
went allogeneic HSCT at least 2 years, discontinued immu-
nosuppressive agents at least 6 months, and had no evidence
of chronic GVHD. The live-attenuated JE vaccine (SA 14-14-2)
was administered to the patients. JE neutralizing Ab titers
were measured before JE vaccination, then at 1st, 3rd, 6th, and
12th months after vaccination by a plaque reduction
neutralizing test. Patients with Ab titer less than 10 at 3rd
month received a second injection at 6th month. Then, the JE
titers were tested at 7th, 9th, 12th, and 18th months. Side ef-
fects of the JE vaccine were recorded by vaccine card sup-
plied to parents or guardians. A total of 28 patients (M:F ¼
11:17) with a median age of 13 years (4-21 years) partici-
pated in the study. The median time from HSCT was 4.13
years (2.1-9.8 years). The underlying diseases were thalas-
semia (50%) and hematologic malignancies (50%). Ten pa-
tients (36%) had Ab in the preventive range before
vaccination (group 1). Nine of 18 patients (50%) sero-
converted at 3rd month after single JE vaccination (group 2)
but only 3 of them had sustained protective Ab levels at 12th
month. Nine patients remained absence of JE Ab after the 1st
injection (group 3). Seven of these 9 patients (78%) sero-
converted at 3rd month after 2nd JE vaccine injection which
all of them could sustain the protective Ab levels at 12th
month. There was no difference of lymphocyte subset (CD4,
8, 16/56, and 19) between these 3 groups. There was no
incidence of systemic reaction reported in this cohort. In
conclusion, post HSCT survivors had low seroconversion rate
after single dose of the live-attenuated JE vaccine (SA 14-14-
2). Post HSCT survivors living in or traveling to the JE
endemic countries may require at least 2 doses of the JE
vaccine to ensure the protective Ab level.300
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Background/Problem: The incidence of hyperglycemia
during and after HSCT has been shown to increase length of
stay as well as the risk of neutropenic infections during
transplantation. Severe hyperglycemia has been shown to
predict the incidence acute graft-versus-host disease. There
is a paucity of literature regarding implementation of a sys-
tematic screening and intervention program within HSCT
programs to proactively address hyperglycemic events and
minimize the potential effects of untreated hyperglycemia.
Intervention: A multi-disciplinary “Hyperglycemia Team”
reviewed the literature and implemented a comprehensive
screening and intervention program. A hyperglycemic proto-
col was implemented on the HSCT units in 2012. All patients
with at least one serum or capillary blood glucose (BG) greaterthan 200 mg/dL in the previous 24 hour period were identi-
ﬁed via computer-generated reports eachmorning. A Certiﬁed
Diabetes Educator (CDE) then screened each patient’s medical
record to assess whether the patient was receiving insulin
therapy to treat hyperglycemia. If the patient was not
receiving insulin therapy or the therapy was inadequate, the
CDE would contact the primary HSCT providers to facilitate
implementation or escalation of a hyperglycemic protocol
and/or an endocrinology team consultation.
Results: All serum and capillary blood glucoses performed
on the inpatient stem cell transplant units were analyzed for
12 months prior to (n¼14780) and subsequent to (n¼15138)
our intervention. The incidence of BG levels > 180 mg/dL
signiﬁcantly decreased by 16% (p¼<.0001) while the inci-
dence of hypoglycemic events (BG levels < 60 mg/dL)
requiring medical intervention signiﬁcantly decreased by
42% (p¼<.0001) (Figure A). The number of blood glucose
levels at the target goal of 100-180 mg/dL signiﬁcantly
increased by 7.8% (p¼<.0001).
Conclusion: A multi-disciplinary approach to the identiﬁ-
cation and treatment of hyperglycemia is essential to
decrease the incidence of hyperglycemia. We concurrently
achieved a signiﬁcant decrease in BG levels and the incidence
of hypoglycemic events requiring medical intervention.
Serum/Capillary Blood Glucose Levels on HSCT Units-
Figure A301
The Effect of Communication Skills Training on Nurses’
Conﬁdence and Competence in Providing Psychosocial
Support to Patients and Families
Sharon Penko. Cancer and Blood Diseases Institute, Cincinnati
Children’s Hospital Medical Center, Cincinnati, OH
Background:Many bone marrow transplant (BMT) patients
and families report clinically signiﬁcant levels of psycho-
logical distress prior to the start of treatment and afterward.
Nurses generally feel conﬁdent in providing care for the
physical needs of patients, but often ﬁnd it more difﬁcult to
address patients’ emotional concerns and report a lack of
skill in this area. Supportive and patient-centered commu-
nication is an important part of nursing practice, especially
with patients who are experiencing emotional and psy-
chological distress, and disruption to social, occupational,
and physical lifestyle. To address this issue, the clinical
question, “Among direct care nurses, does communication
skills training compared to no communication skills
training, affect nurses’ conﬁdence and competence in
providing psychosocial support to patients and families?”
was developed. The ACE Star Model of Evidence-Based
Practice Change: Knowledge Transformation (Stevens,
2012) was used for this project. A literature search was
conducted. Eight articles were critically appraised and a
moderate grade was assigned. Communication skills
training has been shown to be effective at increasing nurses’
ability to provide psychosocial support to patients, conﬁ-
dence in providing psychosocial support, conﬁdence in
handling conﬂicts and criticism, competency in communi-
cating, and communication-related self-efﬁcacy. Nurses
also attended to the psychological and social needs of pa-
tients more effectively and reported that the skills trans-
lated well into the workplace.
Implementation: Communication skills training will be
added to the Therapeutic Collaborative training for BMT
nurses in the spring of 2014. This training aims to assist
nurses in forming therapeutic relationships with their pa-
tients and families, addressing professional boundaries, the
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relates to communication. The training will be offered
utilizing a combination of education strategies including
web-based video and return demonstration with clinical
managers.
Evaluation: The trainingwill be evaluated using pre and post
measures of BMT nurses’ conﬁdence and conﬁdence in
providing psychosocial support to patients and families. Data
will be collected at baseline and at three and six months post
communication skills training.302
The Role of Occupational Therapy and Its Impact on
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Clinical Question (in PICO format)
P (Population/Problem) Among school aged children (3-18
years of age) receiving a stem cell transplant (SCT)*
I (Intervention) Does occupational therapy intervention(s)
C (Comparison)
O (Outcome) Limit the negative affect of SCT on a patient’s
quality of life?
Target Population for the Recommendation (Inclusion /
Exclusion Criteria for the recommendation)
Preschool (3 years) to young adult (18 years) who are
admitted to an inpatient unit to undergo SCT in the protected
environment
Background / Purpose of BESt Development
SCT is a highly risky and aggressive therapeutic approach for
an assortment of formerly incurable malignancies, hemato-
logical disorders, genetic disorders, and metabolic storage
diseases that have evolved dramatically in the past 25 years,
advancing at a rapid pace as scientiﬁc discoveries are trans-
formed into pediatric clinical settings (Tanzi 2011 [1b]).
Throughout the evidence, it is understood that there are
three phases of SCT, which consist of pre-transplant, inpa-
tient hospitalization and post-transplant. This review focuses
on the acute, inpatient phase of SCT, including when the
patient is hospitalized in the protected environment (PE).
Evidence was reviewed with the objectives to delineate the
roles and responsibilities of the OT during the inpatient
phase of SCT, while also improving understanding of how the
role of OT can impact HRQOL.303
Determinants of Early and Late Transfusion Burden after
Hematopoietic Stem Cell Transplantation (HSCT): An
Analysis of 174 Transplant Recipients from a Single Center
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N patients
Disease stage: early vs intermediate vs advanced 42 vs 25 vs 106
Donor: ABO identical vs minor vs major incompatible 98 vs 33
vs 43
Donor: matched related vs unrelated 82 vs 90
Stem cell source: peripheral blood vs marrow vs cord blood 153 vs 14
vs 74 Department of Haematology, Royal Perth Hospital, Perth,
Australia; 5 Haematology, Royal Perth Hospital, Perth, Australia
Aim: Transfusion burden after HSCT in the modern era may
differ from that reported in the early literature regarding
bone marrow transplantation. We sought to quantify the red
cell (RC) and platelet transfusion burden associated with
HSCT at our center and to identify factors associated with
increased transfusions after transplant.
Methods: Patients were included who underwent ﬁrst
allogeneic HSCT at our center from 01/2004-12/2011. The
cumulative number of RC and platelet transfusions for each
patient was recorded at days 30, 90 and 365 post-transplant.
Products were transfused according to clinical need, usually
to maintain hemoglobin >80mg/dL and platelets >10x10e6/
L. Single donor apheresis platelets were used. Donor-recip-
ient pairs were ABO-identical, minor incompatible (donor
antibodies to recipient red cell RC) or major incompatible
(recipient antibodies to donor RC).
Results: 174 patients underwent HSCT for acute leukemia
(47%), other hematological malignancy (44%) or other diag-
nosis (3%) at amedian age of 42 years. Conditioning regimens
were myeloablative in 138 (80%) and reduced intensity in 34
(20%). A median of 12 (range 2-117) ABO group and antibody
screen assays were performed per patient between D0-D365.
All patients received at least one unit of either RC or platelets.
The median number of both RC and platelet units transfused
between D0-D30 was 4 each (range: 0-20 and 0-32 respec-
tively) and this was associated with patient and transplant
characteristics (Table). Post-transplant transfusions were not
inﬂuenced by recipient age, sex or conditioning regimen. Of
162 patients alive at day 31, 45 (28%) received RC and 37
(23%) platelet transfusions between D31-D90. Cord blood
recipients and those who developed grade 2-4 acute GVHD
were more likely to receive both RC (p ¼ 0.03 & p ¼ 0.01,
respectively) and platelets (p ¼ 0.005 & p ¼ 0.01) during this
period. After D90, relapse prior to D365 was the only factor
inﬂuencing both RC and platelet transfusions (p < 0.001 for
both).
Conclusion: The overall transfusion burden after allogeneic
HSCT at our center was lower than we expected. Patients
with advanced malignancies, ABO incompatible donors, and
unrelated or cord blood donors required more transfusions
early post-transplant, while GVHD and relapse were associ-
ated with transfusion after D30. These ﬁndings will inform
our clinical practice and assist the transfusion laboratory to
optimize cost-effectiveness and efﬁciency.304
Effects of Calcineurin Inhibitors on Urinary Sodium
Excretion Early after Allogenic Hematopoietic Stem Cell
Transplantation
Masuho Saburi, Takehiko Mori, Jun Kato, Yuya Koda,
Sumiko Kohashi, Shinichiro Okamoto. Division of Hematology,
Keio University School of Medicine, Tokyo, JapanRed cells (median units) P value Platelets (median units) P value
2 vs 5.5 vs 4 0.08 3 vs 4 vs 5 0.02
4 vs 6 vs 6 <0.001 4 vs 6 vs 4 0.15
4 vs 4.5 0.05 3 vs 5 0.003
4 vs 4 vs 11 0.003 4 vs 7
vs 16
<0.001
